Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
US9877987B2 · kind B2 · utility
2Cited by
10References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2014 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Feb 24, 2034 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01J20/28066
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide spherical activated carbon exhibiting excellent adsorption ability for uremic substances in the body, and particularly for -aminoisobutyric acid. Accordingly, provided is an orally administered adsorbent comprising spherical activated carbon containing not less than 0.5 wt % of nitrogen atoms, having a specific surface area determined by the Brunauer-Emmett-Teller (BET) method of 700 m2/g to 3000 m2, and having an average particle size from 0.01 to 1 mm.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.